1. Home
  2. About

Our story

A mine’s malaria problem became a national programme

AngloGold Ashanti Malaria Control (AGAMal) started in Obuasi in 2005 to protect mine workers and their families. Today it sprays homes across Ghana and manages Global Fund grants for the country.

The AGAMal office building on Mine Road, Obuasi, with the mine headframes behind it

Mission & values

Malaria-free communities

That is our vision. Our mission is to develop, implement and sustain public health interventions that are efficient, effective, economical and measurable.

  • Goal

    Reduce disease

    Contribute to the reduction of diseases of public health importance, in line with national and international priorities.

  • Value

    Safety, health and environment

    Every spray round, lab test and clean-up is planned around the safety of households, staff and surroundings.

  • Value

    Continuous improvement

    Entomology, data and season reviews feed into how the next campaign runs.

  • Value

    Dignity and respect

    Spray operators enter homes only with the householder’s permission and explain each step.

  • Value

    Prudence

    Careful use of donor, government and company funds, with results reported back.

  • Value

    Partnership

    We work with assemblies, health services, researchers and communities on every intervention.

History

Two decades of malaria control

From one municipality to 25 districts at its peak, and from company programme to Global Fund principal recipient.

  1. 2004

    Malaria named the biggest threat

    AngloGold Ashanti identifies malaria as the biggest public health threat to its operations in sub-Saharan Africa.

  2. 2005

    The programme begins in Obuasi

    The mine hospital records over 6,800 malaria cases a month, 2,500 of them mine workers, costing 7,500 shifts a month. A comprehensive malaria control programme launches with a goal of halving malaria in Obuasi within two years of spraying.

  3. 2008

    First private-sector Global Fund recipient

    AGAMal receives a US$133 million Global Fund grant, as the first private-sector principal recipient, to scale indoor residual spraying with the Ministry of Health and National Malaria Control Programme.

  4. 2011

    Spraying in 11 districts

    IRS reaches four districts in Ashanti, one in Central, three in Western and three in Upper West.

  5. 2014

    25 operational districts

    Between 2012 and 2014 the programme grows to 25 districts across Ashanti, Central, Western, Northern, Upper West and Upper East regions. A national reprioritisation then focuses spraying on Upper West, where prevalence was above 50%, while Obuasi continues as AngloGold Ashanti’s own programme.

  6. 2016

    New insecticides, new districts

    Savings from the IVCC and Unitaid NgenIRS initiative fund expansion into three Upper East districts: Builsa North, Builsa South and Kassena Nankana West.

  7. 2024

    Principal Recipient for community systems

    AGAMal is selected to manage the Community Systems Strengthening component of Ghana’s Global Fund HIV, TB and malaria grant for 2024 to 2026.

The result

Monthly cases fell from thousands to a few hundred

AngloGold Ashanti has invested an average of US$1.5 million a year in the programme and has seen work absenteeism from malaria fall by over 90%.

The approach has been replicated at AngloGold Ashanti mine sites in Mali, Guinea and Tanzania.

Line chart of reported malaria cases at Edwin Cade Memorial Hospital from 2005 to 2017, falling from about 6,800 a month to a few hundred
Reported malaria cases, Edwin Cade Memorial Hospital, 2005 to 2017.

Where we work

From Obuasi to the Upper West and Upper East

Spraying districts have changed with national priorities and funding. The map shows the operational districts in 2017.

Meet the team

Map of Ghana showing AGAMal's indoor residual spraying districts in 2017
Indoor residual spraying districts, 2017.

Help us reach malaria-free communities

Volunteer in your community, partner with us on a programme, or see our open position.